Given the increasing attempts by many researchers to quantitatively determine RNA levels from very low or highly degraded sources using commercially available reverse transcriptases, it is surprising that their analytical sensitivity, efficiency, and reproducibility are not extensively explored.
The action of reverse transcriptase makes it possible for genetic material from a retrovirus to become permanently incorporated into the DNA genome of an infected cell; the enzyme is widely used in the biological sciences to synthesize genes.
As these analogues have not shown in vitro HIV-2 reverse transcriptase inhibition, it could be excluded as potential target for their specific anti-HIV-2 activity.
Briefly, a first cDNA synthesis was performed with oligo dT primers supplied by manufacturer, and dC residues were introduced by the reverse transcriptase when it reached the mRNA end.
hTEP1 is associated with telomerase activity and the telomerase reverse transcriptase, and it specifically interacts with the telomerase RNA (Dhaene et al, 2000).
Even if the non-LTR element could not produce a functional reverse transcriptase enzyme, it is possible that fully functional retrotransposon machinery from elsewhere in the genome recognized a still-intact promoter and target sequence for retrotransposition of the SDR.
In summary, this method of selecting full-length cDNAs by biotinylation of the mRNA cap and streptavidin capture followed by the use of the trehalose-thermostabilized reverse transcriptase, made it possible to prepare longer full-length cDNAs, and at the same time to remove non-full-length cDNAs [ 24, 25].
When it infects a cell, the virus deploys a special enzyme, called reverse transcriptase, that enables it to copy itself and then paste its own genes into the new cell's DNA.
Due to the RNase H activity in HIV reverse transcriptase (HIV-RT), it represents a promising target for anti-HIV drug design.
